FCB Health Europe Revenue and Competitors
Estimated Revenue & Valuation
- FCB Health Europe's estimated annual revenue is currently $9M per year.
- FCB Health Europe's estimated revenue per employee is $200,000
Employee Data
- FCB Health Europe has 45 Employees.
- FCB Health Europe grew their employee count by -22% last year.
FCB Health Europe's People
Name | Title | Email/Phone |
---|
FCB Health Europe Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $156.9M | 502 | 1% | N/A | N/A |
#2 | $16.2M | 72 | 6% | N/A | N/A |
#3 | $4M | 23 | -39% | N/A | N/A |
#4 | $31.3M | 125 | -4% | N/A | N/A |
#5 | $25M | 100 | -7% | N/A | N/A |
#6 | $191.6M | 613 | 18% | N/A | N/A |
#7 | $34.5M | 138 | 0% | N/A | N/A |
#8 | $155.9M | 499 | 4% | N/A | N/A |
#9 | $858.4M | 2401 | -15% | $5M | N/A |
#10 | $28.5M | 114 | 7% | N/A | N/A |
What Is FCB Health Europe?
At FCB Health Europe, part of the Cannes Lions Healthcare Network of the Year, we risk more, care more and dream more than others. We believe the current model of advertising agencies working in silos within networks has had its time. We're a collaborative, award-winning creative hub that recruits the best people, wherever they are, and wherever our clients need them. We employ cutting-edge strategy to produce innovative solutions to meet our clients' needs. We make the complex simple.
keywords:N/AN/A
Total Funding
45
Number of Employees
$9M
Revenue (est)
-22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
FCB Health Europe News
2022-04-17 - IPG Health Sweeps the 2022 Manny Awards
Best Medical Device Campaign Woojer and AREA 23: Sick Beats. Best Nonbranded Campaign Novartis, Aimovig and FCB Health Europe: Is Your Pain...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8.8M | 45 | 25% | N/A |
#2 | $6.2M | 45 | 25% | N/A |
#3 | $5.2M | 45 | 7% | N/A |
#4 | $5.2M | 45 | 36% | N/A |
#5 | $7.5M | 45 | 15% | N/A |